<?xml version="1.0" encoding="utf-8"?>
    <RequestData>
      <RequestDataID>1116910</RequestDataID>
      <RequestID>1109</RequestID>
      <PacketNumber>2</PacketNumber>
      <ActionType>Export</ActionType>
      <CDRDocType>GlossaryTerm</CDRDocType>
      <GKDocType>GlossaryTerm</GKDocType>
      <CdrID>46583</CdrID>
      <CdrVersion>10</CdrVersion>
      <Status>OK</Status>
      <DependencyStatus>OK</DependencyStatus>
      <Location>GateKeeper</Location>
      <GroupID>2</GroupID>
      <XML>
        <GlossaryTerm id="CDR0000046583">
          <TermName>smoldering leukemia</TermName>
          <TermPronunciation>(SMOLE-der-ing loo-KEE-mee-uh)</TermPronunciation>
          <TermDefinition>
            <DefinitionText>A group of diseases in which the bone marrow does not make enough healthy blood cells. Also called myelodysplastic syndromes and preleukemia.</DefinitionText>
            <Dictionary>Cancer.gov</Dictionary>
            <Audience>Patient</Audience>
          </TermDefinition>
          <SpanishTermName>leucemia latente</SpanishTermName>
          <SpanishTermDefinition>
            <DefinitionText>Enfermedad en la cual la médula ósea no funciona normalmente. También se llama preleucemia y síndrome mielodisplásico.</DefinitionText>
            <Dictionary>Cancer.gov</Dictionary>
            <Audience>Patient</Audience>
          </SpanishTermDefinition>
          <DateLastModified>2007-04-26</DateLastModified>
          <RelatedInformation>
            <RelatedSummaryRef UseWith="en" href="CDR0000378089">Myelodysplastic Syndromes Treatment</RelatedSummaryRef>
            <RelatedSummaryRef UseWith="es" href="CDR0000426393">Síndromes mielodisplásicos: Tratamiento</RelatedSummaryRef>
          </RelatedInformation>
        </GlossaryTerm>
      </XML>
    </RequestData>
